全文获取类型
收费全文 | 5456篇 |
免费 | 381篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 173篇 |
妇产科学 | 120篇 |
基础医学 | 663篇 |
口腔科学 | 197篇 |
临床医学 | 409篇 |
内科学 | 1258篇 |
皮肤病学 | 134篇 |
神经病学 | 252篇 |
特种医学 | 107篇 |
外国民族医学 | 4篇 |
外科学 | 813篇 |
综合类 | 187篇 |
一般理论 | 4篇 |
预防医学 | 457篇 |
眼科学 | 110篇 |
药学 | 530篇 |
中国医学 | 72篇 |
肿瘤学 | 313篇 |
出版年
2023年 | 73篇 |
2022年 | 44篇 |
2021年 | 255篇 |
2020年 | 178篇 |
2019年 | 230篇 |
2018年 | 212篇 |
2017年 | 167篇 |
2016年 | 219篇 |
2015年 | 226篇 |
2014年 | 265篇 |
2013年 | 332篇 |
2012年 | 487篇 |
2011年 | 521篇 |
2010年 | 268篇 |
2009年 | 215篇 |
2008年 | 337篇 |
2007年 | 263篇 |
2006年 | 282篇 |
2005年 | 257篇 |
2004年 | 208篇 |
2003年 | 155篇 |
2002年 | 172篇 |
2001年 | 27篇 |
2000年 | 33篇 |
1999年 | 35篇 |
1998年 | 27篇 |
1997年 | 21篇 |
1996年 | 18篇 |
1995年 | 24篇 |
1994年 | 24篇 |
1993年 | 25篇 |
1992年 | 20篇 |
1991年 | 9篇 |
1990年 | 19篇 |
1989年 | 23篇 |
1988年 | 18篇 |
1987年 | 25篇 |
1986年 | 14篇 |
1985年 | 8篇 |
1984年 | 8篇 |
1983年 | 14篇 |
1982年 | 14篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 9篇 |
1975年 | 8篇 |
1974年 | 6篇 |
1973年 | 4篇 |
排序方式: 共有5867条查询结果,搜索用时 46 毫秒
91.
Abdul?MannanEmail author Ariful?Basher?Abir Rashidur?Rahman 《BMC complementary and alternative medicine》2015,15(1):337
Background
Bacopa monniera has been used as a cure for various ailments that include anxiety, epileptic disorders, dementia, blood purifier, cough and rheumatism, and some important local uses of the plant are in dermatitis, anemia, diabetes, promote fertility and prevent miscarriage for many years in Bangladesh. According to this background, the aim of the study was to evaluate the antidepressant-like effect of the methanolic extract of B. monniera (MEBM) in different behavioral models such as forced swimming test (FST), measurement of locomotor activity test (MLAT) and tail suspension test (TST) on mice after two weeks treatment.Methods
Mice were divided into five groups (n?=?5/group): control group (deionized water), standard group where Imipramine hydrochloride (30 mg/kg) was used as standard drug and three test groups where three doses of the methanolic extract of B. monniera (MEBM) (50, 100, and 200 mg/kg) was used for two weeks treatment. All the drug and test samples were administered via gavage through oral route. To assess the antidepressant-like effect of MEBM forced swimming test (FST), tail suspension test (TST) and measurement of locomotor activity test (MLAT) have been done in mice.Results
The results showed that a strong and dose-dependent antidepressant effects in different mice models. The main findings of the MEBM significantly reduced the duration of immobility times in the forced swimming test (p?<?0.001). Likewise, the extract significantly decreased the immobility time in the tail suspension test (p?<?0.001). Moreover, we employed an additional measurement of locomotor activity test to check the motor stimulating activity of the MEBM. The extract also significantly increased the locomotion, rearing and defecation effects in comparison to the control group (p?<?0.001).Conclusion
The present results clearly demonstrate that the methanolic extract of B. monniera possesses antidepressant-like activity in the animal behavioral models. The current study warrants further investigation into identification of the active compounds in herbal medicines, in particular extract of B. monniera with antidepressant-like effects.92.
93.
New recessive truncating mutation in LTBP3 in a family with oligodontia,short stature,and mitral valve prolapse 下载免费PDF全文
94.
Luiz Sergio Azevedo Lígia Camera Pierrotti Edson Abdala Silvia Figueiredo Costa Tania Mara Varej?o Strabelli Silvia Vidal Campos Jéssica Fernandes Ramos Acram Zahredine Abdul Latif Nadia Litvinov Natalya Zaidan Maluf Helio Hehl Caiaffa Filho Claudio Sergio Pannuti Marta Heloisa Lopes Vera Aparecida dos Santos Camila da Cruz Gouveia Linardi Maria Aparecida Shikanai Yasuda Heloisa Helena de Sousa Marques 《Clinics (S?o Paulo, Brazil)》2015,70(7):515-523
95.
96.
Mohammad Amir Hossain Qiang Nai Ping Zhang Hongxiu Luo Mohammed Amzad Hossain Abdul Mahmad Abdalla M. Yousif Shuvendu Sen 《Case reports in oncology》2015,8(1):58-63
Multiple myeloma is the fourteenth cause of cancer-related death. The symptoms of myeloma are mostly nonspecific, and there is significant delay between the first symptoms and diagnosis of myeloma. Atopic eczema is a common chronic inflammatory skin disease associated with dysregulation of the immune system. It generally develops in early childhood but can also occur in adults. Eczema is associated with a variety of hematological and solid malignancies, and possibly multiple myeloma. We report a patient with eczema that developed 5 years before the diagnosis of multiple myeloma but was mistaken for psoriasis.Key Words: Multiple myeloma, Atopic eczema, Early symptoms, Diagnostic criteria 相似文献
97.
TIPS versus paracentesis for the treatment of refractory ascites 总被引:1,自引:0,他引:1
Lau A Bay C Nadir A 《Hepatology (Baltimore, Md.)》2004,40(6):1476; author reply 1476-1476; author reply 1477
98.
99.
Abdul Wadood Khan Sabna Kotta Shahid Husain Ansari Rakesh Kumar Sharma 《Drug delivery》2015,22(4):552-561
AbstractNaringenin (NRG), predominant flavanone in grapefruits, possesses anti-inflammatory, anti-carcinogenic, hepato-protective and anti-lipid peroxidation effects. Slow dissolution after oral ingestion due to its poor solubility in water, as well as low bioavailability following oral administration, restricts its therapeutic application. The study is an attempt to improve the solubility and bioavailability of NRG by employing self-nanoemulsifying drug delivery technique. Preliminary screening was carried out to select oil, surfactant and co-surfactant, based on solubilization and emulsification efficiency of the components. Pseudo ternary phase diagrams were constructed to identify the area of nanoemulsification. The developed self-nanoemulsifying drug delivery systems (SNEDDS) were evaluated in term of goluble size, globule size distribution, zeta potential, and surface morphology of nanoemulsions so obtained. The TEM analysis proves that nanoemulsion shows a droplet size less than 50?nm. Freeze thaw cycling and centrifugation studies were carried out to confirm the stability of the developed SNEDDS. In vitro drug release from SNEDDS was significantly higher (p?<?0.005) than pure drug. Furthermore, area under the drug concentration time-curve (AUC0–24) of NRG from SNEDDS formulation revealed a significant increase (p?<?0.005) in NRG absorption compared to NRG alone. The increase in drug release and bioavailability as compared to drug suspension from SNEDDS formulation may be attributed to the nanosized droplets and enhanced solubility of NRG in the SNEDDS. 相似文献
100.
Abdul Ahad Fahad I. Al-Jenoobi Abdullah M. Al-Mohizea Naseem Akhtar Mohammad Raish Mohd. Aqil 《Saudi Pharmaceutical Journal》2015,23(6):587-602
Hypertension is the most common cardiovascular disease worldwide. Moreover, management of hypertension requires long-term treatment that may result in poor patient compliance with conventional dosage forms due to greater frequency of drug administration. Although there is availability of a plethora of therapeutically effective antihypertensive molecules, inadequate patient welfare is observed; this arguably presents an opportunity to deliver antihypertensive agents through a different route. Ever since the transdermal drug delivery came into existence, it has offered great advantages including non-invasiveness, prolonged therapeutic effect, reduced side effects, improved bioavailability, better patient compliance and easy termination of drug therapy. Attempts were made to develop the transdermal therapeutic system for various antihypertensive agents, including β-blockers, an important antihypertensive class. β-blockers are potent, highly effective in the management of hypertension and other heart ailments by blocking the effects of normal amounts of adrenaline in the heart and blood vessels. The shortcomings associated with β-blockers such as more frequent dose administration, extensive first pass metabolism and variable bioavailability, make them an ideal candidate for transdermal therapeutic systems. The present article gives a brief view of different β-blockers formulated as transdermal therapeutic system in detail to enhance the bioavailability as well as to improve patient compliance. Constant improvement in this field holds promise for the long-term success in technologically advanced transdermal dosage forms being commercialized sooner rather than later. 相似文献